Open original FDA record ↗Recall record
- FDA identifier
- Z-2190-2013
- Company in FDA record
- HemoCue AB
- FDA classification date
- Sep 11, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
During a complaint investigation HemoCue AB discovered punctured HemoCue Glucose 201 single pack pouches.
Source facts
- Action
- HemoCue sent an Urgent Field Safety Notice dated July 12, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to quarantine any affected product and Return the Field Safety Notice Verification Form to e-mail: 2013glufsn@hemocue.com or fax 562-668-5794 Customers would be contacted to coordinate return and replacement of the affected microcuvettes. Customers with questions were instructed to call 800-426-7256. For questions regarding this recall call 440-925-3485.
- Initiated
- 2013-07-15
- Root cause
- Packaging
- Terminated
- 2014-09-02
- Distribution
- Worldwide Distribution - USA (nationwide) and internationally to AUSTRALIA, BELGIUM, CANADA, COTE D'IVOIRE, DENMARK, EGYPT, FINLAND, FRANCE, GEORGIA, GERMANY, GREECE, IRELAND, ITALY, KENYA, NETHERLANDS, NEW ZEALAND, NORWAY, OMAN, POLAND, QATAR, RUSSIAN FEDERATION, SPAIN, SWEDEN, SWITZERLAND, UNITED KINGDOM, VIET NAM & YEMEN. .
- Recall number
- Z-2190-2013
- Recall status
- Terminated
- CDRH record ID
- 120508
- FDA classified
- 2013-09-11
- Recall event number
- 65854